Clinical Trials
5
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients
- Conditions
- Metastatic Breast CancerBreast Cancer
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2015-06-19
- Lead Sponsor
- Janssen Diagnostics, LLC
- Registration Number
- NCT02111031
- Locations
- 🇺🇸
Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2012-10-04
- Last Posted Date
- 2017-03-08
- Lead Sponsor
- Janssen Diagnostics, LLC
- Target Recruit Count
- 121
- Registration Number
- NCT01701050
- Locations
- 🇺🇸
Arizona Oncology Associates, Phoenix, Arizona, United States
🇺🇸Florida Cancer Specialists, St. Petersburg, Florida, United States
🇺🇸Dana-Faber Cancer Institute, Boston, Massachusetts, United States
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
- Conditions
- Breast Cancer
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2016-01-12
- Lead Sponsor
- Janssen Diagnostics, LLC
- Target Recruit Count
- 233
- Registration Number
- NCT00595023
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸Morton Plant Hospital, Clearwater, Florida, United States
GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
- Conditions
- Breast Cancer
- First Posted Date
- 2008-01-16
- Last Posted Date
- 2016-01-12
- Lead Sponsor
- Janssen Diagnostics, LLC
- Target Recruit Count
- 461
- Registration Number
- NCT00595296
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Georgetown University Medical Center, Washington, District of Columbia, United States
🇺🇸Morton Plant Hospital, Clearwater, Florida, United States
Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2007-10-30
- Last Posted Date
- 2016-01-12
- Lead Sponsor
- Janssen Diagnostics, LLC
- Target Recruit Count
- 80
- Registration Number
- NCT00551278
- Locations
- 🇺🇸
Indiana University Hospital, Indianapolis, Indiana, United States